One item not mentioned in the test/partnership pipeline info today (and which may result in new OEM supply ann anytime?)
- Access Bio is still proceeding with a new HIV self-test certification for EU market (using AT1's OEM device).
I had posted about this many months ago. Looks like Access Bio still has their new HIV test 'in-progress' (I presume its AccBio's proprietary test strip as AT1's HIV test is already approved in EU under Owen Mumford brand, so this is not just another re-branding)
Access Bio's 2021 half-yearly released on 17 Aug'21(FYI, Sth Korea KRX financial year follows Jan-Dec calendar cycle) http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210817001177 - pages 20/21 (Section II, Item 6, Major Contracts and R&D activities)
PS: and yes, Access Bio continues to make whopping rev amonth from their Covid19 PCR and RDT sales. AT1 can't match their scale for sale qty but despite the high USA vaccination rates, seems like RDT test sales have only increased there.
